BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16909623)

  • 1. [Synthesis of 5-fluorouracil derivatives containing alkanoic acid].
    Xu LH; Weng LL; Zheng H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):644-6. PubMed ID: 16909623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis of N1-(aryl)alkyloxyacyl-5-fluorouracil derivatives].
    Hai L; Wu LY; Huang J; Cheng L; Wu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):552-4. PubMed ID: 15291126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis and antitumor activity of new heterocyclic 5-fluorouracil derivatives].
    Mao M; Chen Y; Tian X
    Yao Xue Xue Bao; 1998 May; 33(5):389-91. PubMed ID: 12017008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FTIR studies of chlorobenly-5-fluorouracil porphyrin].
    He SM; Liu YQ; Qiu H; Cui WY
    Guang Pu Xue Yu Guang Pu Fen Xi; 2003 Feb; 23(1):49-53. PubMed ID: 12939966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of targeted drug delivery system for fluorouracil using sulfadiazine as the carrier.
    Hu XG; Wang SM; Zhang QX; Cao MM; Lu Y
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1042-4. PubMed ID: 12433646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characteristics of the fluorouracil-dextran conjugates.
    Hao AJ; Deng YJ; Suo XB; Cao YH
    Pharmazie; 2006 May; 61(5):489-90. PubMed ID: 16724554
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and antitumor activity of 1- or 3-(alpha-hetero substituted)alkyl-5-fluorouracil derivatives.
    Ozaki S; Nagase T; Ahmad S; Tamai H; Hoshi A; Iigo M
    Nucleic Acids Symp Ser; 1987; (18):1-4. PubMed ID: 3697106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antitumor activity of 5-fluorouracil derivatives.
    Ozaki S
    Med Res Rev; 1996 Jan; 16(1):51-86. PubMed ID: 8788214
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of novel dioxane nucleosides having two bases, physico-chemical properties, and their biological activities.
    Kajimoto N; Yamaizumi J; Aida M; Harada K; Maeda M
    Nucleic Acids Symp Ser; 1997; (37):5-6. PubMed ID: 9585971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
    Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
    Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship in Ftorafur (Tegafur) and related 5-FU prodrugs.
    Zhuk R
    Adv Exp Med Biol; 1998; 431():677-80. PubMed ID: 9598151
    [No Abstract]   [Full Text] [Related]  

  • 12. N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate).
    Schott H; Goltz D; Schott TC; Jauch C; Schwendener RA
    Bioorg Med Chem; 2011 Jun; 19(11):3520-6. PubMed ID: 21536448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthesis and properties of 5-fluorouracil derivatives].
    Semakov AV; Blinkov AA; Gaenko GP; Vostrova AG; Molotkovskiĭ IuG
    Bioorg Khim; 2013; 39(3):338-45. PubMed ID: 24397032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the synthesis of chemotherapeutics. 10. Synthesis and antitumor activity of N-acyl- and N-(alkoxycarbonyl)-5-fluorouracil derivatives.
    Kametani T; Kigasawa K; Hiiragi M; Wakisaka K; Haga S; Nagamatsu Y; Sugi H; Fukawa K; Irino O; Yamamoto T; Nishimura N; Taguchi A; Okada T; Nakayama M
    J Med Chem; 1980 Dec; 23(12):1324-9. PubMed ID: 7452684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface-enhanced Raman scattering of 5-fluorouracil adsorbed on silver nanostructures.
    Sardo M; Ruano C; Castro JL; López-Tocón I; Soto J; Ribeiro-Claro P; Otero JC
    Phys Chem Chem Phys; 2009 Sep; 11(34):7437-43. PubMed ID: 19690716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and bioevaluation of 5-fluorouracil derivatives.
    Tian ZY; Du GJ; Xie SQ; Zhao J; Gao WY; Wang CJ
    Molecules; 2007 Nov; 12(11):2450-7. PubMed ID: 18065949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-phase synthesis of 1-substituted tetrahydroisoquinoline derivatives employing BOC-protected tetrahydroisoquinoline carboxylic acids.
    Bunin BA; Dener JM; Kelly DE; Paras NA; Tario JD; Tushup SP
    J Comb Chem; 2004; 6(4):487-96. PubMed ID: 15244409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and release of 5-fluorouracil from poly(N-vinylpyrrolidinone) bearing 5-fluorouracil derivatives.
    Liu Z; Rimmer S
    J Control Release; 2002 May; 81(1-2):91-9. PubMed ID: 11992682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient synthesis of heterocyclic compounds using ethenetricarboxylic acid diesters.
    Yamazaki S; Iwata Y; Fukushima Y
    Org Biomol Chem; 2009 Feb; 7(4):655-9. PubMed ID: 19194579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative activity, cell-cycle dysregulation, and cellular differentiation: salicyl- and catechol-derived acyclic 5-fluorouracil O,N-acetals against breast cancer cells.
    Marchal JA; Rodríguez-Serrano F; Caba O; Aránega A; Gallo MA; Espinosa A; Campos JM
    ChemMedChem; 2007 Dec; 2(12):1814-21. PubMed ID: 17969215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.